Option program in BioInvent International AB (SE)

Carnegie acted as adviser to BioInvent in the offer to employees and management to purchase warrants issued by BioInvent International AB. By use of its technology platform BioInvent International AB is a partner to pharmaceutical companies within therapeutic antibodies and antibodies for use as discovery tools.June, 2001.